AnalystsTrevor AllredTrevor Allred's Stock Forecasts
AnalystsTrevor Allred
Sectors:
Industries:
Analyst Ranking
Top 14%
#780 out of 5550 analysts
Average Return
+82.2%
Win Rate
83%15 out of 18
Risk vs Reward
Poor
Good
Trevor Allred's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mbx Biosciences IncMBX | +388.13% | $12.43 | $60.68 | 2025-07-16 - 2026-07-15 | Buy |
Mbx Biosciences IncMBX | +226.90% | $18.96 | $61.98 | 2025-09-23 - 2026-09-22 | Buy |
Palvella Therapeutics IncPVLA | +168.52% | $56.71 | $152.28 | 2025-09-09 - 2026-09-08 | Buy |
Ligand Pharmaceuticals IncLGND | +112.98% | $135.23 | $288.01 | 2025-07-30 - 2026-07-29 | Buy |
Ligand Pharmaceuticals IncLGND | +111.92% | $104.48 | $221.41 | 2025-05-09 - 2026-05-08 | Buy |
Trevor Allred Analyst Color
Get additional color on Trevor Allred's coverage of popular stocks
Trevor Allred's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Legend Biotech CorpLEGN | 2 | Hold | $40.00 | +84.93% | Downgrades | 3 months ago |
Theravance Biopharma IncTBPH | 2 | Hold | N/A | N/A | Downgrades | 8 months ago |
Ligand Pharmaceuticals IncLGND | 9 | Buy | $277.00 | -14.18% | Maintains | 8 months ago |
Bridgebio Pharma IncBBIO | 2 | Buy | $81.00 | +8.07% | Maintains | 8 months ago |
Design Therapeutics IncDSGN | 1 | Buy | $18.00 | +68.54% | Initiates Coverage On | 10 months ago |
Mbx Biosciences IncMBX | 2 | Buy | $80.00 | N/A | Maintains | a year ago |
Palvella Therapeutics IncPVLA | 1 | Buy | $85.00 | N/A | Initiates Coverage On | a year ago |
Innoviva IncINVA | 1 | Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.